CELEX: 62013TB0482
Language: en
Date: 2018-02-21 00:00:00
Title: Case T-482/13: Order of the General Court of 21 February 2018 — MedSkin Solutions Dr. Suwelack v EUIPO — Cryo-Save (CryoDafe) (EU trade mark — Opposition proceedings — Withdrawal of the opposition — No need to adjudicate)

30.4.2018   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               C 152/34
            
         Order of the General Court of 21 February 2018 — MedSkin Solutions Dr. Suwelack v EUIPO — Cryo-Save (CryoDafe)
   (Case T-482/13) (1)
   
   ((EU trade mark - Opposition proceedings - Withdrawal of the opposition - No need to adjudicate))
   (2018/C 152/43)
   Language of the case: German
   
      Parties
   
   
      Applicant: MedSkin Solutions Dr. Suwelack AG (Billerbeck, Germany) (represented by: A. Thünken, lawyer)
   
      Defendant: European Union Intellectual Property Office (represented by: A. Schifko, acting as Agent)
   
      Other party to the proceedings before the Board of Appeal of EUIPO intervening before the General Court: Cryo-Save AG (Freienbach, Switzerland) (represented by: C. Onken, lawyer)
   
      Re:
   
   Action brought against the decision of the Fourth Board of Appeal of EUIPO of 4 July 2013 (Case R 1759/2012 4), relating to opposition proceedings between Cryo-Save AG and MedSkin Solutions Dr. Suwelack AG.
   
      Operative part of the order
   
   
               1.
            
            
               There is no longer any need to adjudicate in the action;
            
         
               2.
            
            
               MedSkin Solutions Dr. Suwelack AG and Cryo-Save AG are ordered to jointly and severally to bear the costs incurred by the European Union Intellectual Property Office (EUIPO);
            
         
               3.
            
            
               MedSkin Solutions Dr. Suwelack AG et Cryo-Save AG are ordered to bear their own costs in accordance with the terms of their agreement.
            
         
      (1)  OJ C 313, 26.10.2013.